Skip to content
HabitSeek
Back to results

Review urolithin A supplementation

Evaluate urolithin A supplementation in light of preliminary human muscle-function research and its limits.

At a glance

  • Evidence: Small trials found some muscle-test improvements with urolithin A.Muscle endurance, strength and physical function · Limited certainty · Randomized intervention
  • What’s uncertain: Key primary outcomes were not improved, and longevity benefits are unproven.
  • First step: Review the actual trial outcome and formulation before buying a product.
  • Before you try it: Keep exercise and rehabilitation central when addressing weakness or poor function. All precautions

Takeaway

Four-month trials reported some gains in muscle endurance or strength, while the older-adult trial did not significantly improve its primary walking-distance or ATP outcomes and the middle-aged trial missed peak power. A human systematic review likewise found no clear physical-function or cardiovascular benefit. Industry involvement and short follow-up reinforce the need for independent replication. Pomegranate or other precursor-rich foods are not equivalent to the tested urolithin A products.

Pomegranate seeds, an illustrative source of precursors; the trials tested a urolithin A supplement rather than this food.Discussed by2 peopleView statements ↓
ExerciseLong-term healthUnder 10 min · Easy · High
Reviewed Oct 3, 2026
Save

Scientific evidence

What the research shows

Outcome assessments based on research, including its uncertainties and limitations.

Muscle endurance, strength and physical function

Finding: Mixed evidenceCertainty: Limitedstudies disagree, or the effect depends on who is studied

Evidence basis: randomised trials

Some muscle measures improved, but key primary functional outcomes did not.

Population: Older adults aged 65–90 years and middle-aged adults in four-month placebo-controlled trials.

Research details

Summary

A 66-person older-adult trial reported improved endurance measures but no significant improvement in six-minute walk distance or maximal ATP production compared with placebo. A middle-aged-adult trial reported strength changes but missed its primary peak-power outcome. The human review supports further research rather than proven restoration of everyday function or longevity.

Why this certainty

Limited because the trials are randomized but primary and secondary findings differ and independent long-term replication is lacking.

Limitations

Small samples, multiple secondary measures and short duration limit certainty. The trials had industry involvement, and biomarkers cannot establish longevity or independence in daily life.

Sources for this outcome:

What people say

Who discusses this?

Public statements, with positions specific to each source and topic. These views do not determine the scientific evidence assessment.

What the research shows ↑

Practical steps and precautions

How to try it

  1. Treat the product as an optional emerging intervention, with a specific outcome to evaluate rather than a longevity promise.
  2. Prioritize a sustainable exercise routine and adequate nutrition before purchasing an expensive supplement.
  3. Review the exact formulation, trial population and product quality; do not assume precursor foods reproduce the supplement trial.
  4. Discuss suitability if you have a medical condition or take medicines, and reconsider ongoing use if it has no clear value for you.

Precautions

  • Small short trials cannot establish long-term safety or benefits during pregnancy or childhood.
  • Do not replace rehabilitation, exercise or treatment for weakness with a mitophagy marketing claim.

References

Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial.

Liu S, D'Amico D, Shankland E, Bhayana S, Garcia JM, Aebischer P, Rinsch C, Singh A, Marcinek DJ. · JAMA network open · 2022

Randomized double-blind four-month placebo-controlled trial in 66 older adultsVerified from full text
Open original source

Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults.

Singh A, D'Amico D, Andreux PA, Fouassier AM, Blanco-Bose W, Evans M, Aebischer P, Auwerx J, Rinsch C. · Cell reports. Medicine · 2022

Randomized placebo-controlled four-month trial in middle-aged adultsVerified from full text
Open original source

Targeting aging with urolithin A in humans: A systematic review.

Kuerec AH, Lim XK, Khoo AL, Sandalova E, Guan L, Feng L, Maier AB. · Ageing research reviews · 2024

Systematic reviewSystematic review of five human studies involving 250 healthy individualsVerified from abstract
Open original source

Community

Discussion

Have you tried this? What helped or made it difficult?

Reader experiences are separate from the scientific evidence. Explore all discussions

No discussions yet.

Be the first to ask a question or share your experience.

Sign in to vote or join the discussion.

Related habits

Explore other habits in a shared category. Each has its own evidence and precautions.

Editorial history and review method

Revision 3 · Approved for publication · HabitSeek site owner (publication approval); Codex discovery audit

Prepared and checked with AI. Publication approval does not imply independent expert review. Request a correction.

New revision-1 Standard draft. Evidence and original-video attribution are separate. Check practice matching, population and formulation limits, null results and safety wording before independent approval. Sources: liu-2022-urolithin-older-adults, singh-2022-urolithin-middle-age, kuerec-2024-urolithin-human-review. Publication release 2026-10-04: site owner authorized a bounded AI audit and release of this exact revision. See docs/release-audit-2026-10-04.md for source-check findings and limits. No independent health-professional or peer review is claimed. Category migration 2026-10-04: removed the separate goals field; categories: Exercise, Long-term health → Exercise, Long-term health. Research assessments, sources, guidance, precautions, and evidence review dates are unchanged. This revision awaits publication approval; no new evidence review is claimed. Publication approval 2026-10-04: site owner explicitly accepted all current category-migration revisions for deployment and requested that remaining limitations be retained in docs/content-review-backlog.md. Approval applies to this exact content revision. No new evidence review, independent expert review, or clinical validation is claimed; existing precautions and disclosures remain in effect. Discovery audit 2026-10-10: added familiar search aliases. Outcome assessments, evidence sources, practical guidance, precautions and evidence-review date are unchanged. Formulation aliases identify the topic covered, not an endorsement or a new effectiveness claim. This exact revision awaits publication approval. Publication approval 2026-10-10: site owner answered 'Approve and publish' to the question explicitly covering these eight naming/search revisions and deployment to habitseek.com. Approval applies to this exact revision. Evidence assessments, guidance, precautions and scientific review dates were unchanged by the discovery audit. This is publication approval, not independent expert or clinical validation. The 15 later supplement drafts are outside this approval.